Prolto(SZ:002769)2022-12-07 00:01Group 1: Company Overview - The company, Shenzhen Pulutong Supply Chain Management Co., Ltd., received approval for a non-public stock issuance on April 29, 2016, with expected approval from the China Securities Regulatory Commission by mid-August 2016 [1]. - The transaction value handled by the company in 2014 and 2015 was 38 billion and 43.8 billion respectively, focusing on the ICT and medical device industries [1]. Group 2: Supply Chain Advantages - The company optimizes the sales process in the medical device sector by acting as an integrator among manufacturers, agents, and end-users, which reduces sales levels, shortens order cycles, and lowers logistics, labor, and inventory costs, ultimately enhancing supply chain efficiency and reducing procurement prices for end-users [1]. Group 3: Business Expansion Plans - The company is focusing on two key areas for business expansion: financing leasing and cross-border e-commerce [2]. - Financing leasing is part of the company's supply chain financial services, which will enhance the overall service chain for medical devices after obtaining the financing leasing license [2]. - Cross-border e-commerce is identified as a future development direction, with plans to establish a wholly-owned subsidiary in Qianhai and expand nationwide through self-built or acquisition strategies within 2-3 years [2].